CD28 and cancer: To determine if MDSCs inhibit the activity of T cells, we purified MDSCs from one healthy donor and two patients with stage IV cancer (Fig. 6A) and cocultured them with or without CFSE-labeled autologous CD3+ T cells at the 1∶2 ratios in the absence or presence of CD3/CD28 antibody stimulation for 3 days.